Two Sigma Advisers LP grew its stake in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,500 shares of the company's stock after acquiring an additional 13,700 shares during the quarter. Two Sigma Advisers LP owned about 0.70% of TruBridge worth $2,061,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Tower Research Capital LLC TRC increased its stake in TruBridge by 47.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company's stock valued at $43,000 after purchasing an additional 699 shares in the last quarter. Covestor Ltd grew its holdings in shares of TruBridge by 20.5% during the fourth quarter. Covestor Ltd now owns 2,819 shares of the company's stock valued at $56,000 after buying an additional 479 shares during the last quarter. AlphaQuest LLC purchased a new stake in shares of TruBridge during the fourth quarter valued at $66,000. EMC Capital Management increased its position in shares of TruBridge by 2,704.0% in the 4th quarter. EMC Capital Management now owns 5,608 shares of the company's stock valued at $111,000 after acquiring an additional 5,408 shares during the period. Finally, R Squared Ltd purchased a new position in TruBridge in the 4th quarter worth $154,000. 88.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
TBRG has been the topic of several research analyst reports. Cantor Fitzgerald boosted their price target on TruBridge from $20.00 to $29.00 and gave the company an "overweight" rating in a research note on Tuesday, March 11th. Stephens reaffirmed an "equal weight" rating and set a $28.00 target price on shares of TruBridge in a report on Thursday, April 10th.
Get Our Latest Stock Report on TBRG
TruBridge Stock Performance
Shares of TruBridge stock traded down $0.18 during trading on Monday, hitting $23.75. 128,744 shares of the company's stock were exchanged, compared to its average volume of 128,869. The stock has a market capitalization of $356.80 million, a price-to-earnings ratio of -5.81, a PEG ratio of 5.38 and a beta of 0.65. The business has a 50-day simple moving average of $25.14 and a 200-day simple moving average of $23.81. TruBridge, Inc. has a 52-week low of $8.99 and a 52-week high of $32.00. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80.
TruBridge (NASDAQ:TBRG - Get Free Report) last announced its quarterly earnings results on Friday, May 9th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.08). The company had revenue of $87.21 million for the quarter, compared to analyst estimates of $86.21 million. TruBridge had a positive return on equity of 1.78% and a negative net margin of 17.72%. On average, research analysts forecast that TruBridge, Inc. will post 0.07 EPS for the current year.
Insider Buying and Selling
In related news, CEO Christopher L. Fowler sold 6,000 shares of the business's stock in a transaction on Friday, May 16th. The shares were sold at an average price of $25.05, for a total value of $150,300.00. Following the completion of the transaction, the chief executive officer now directly owns 131,090 shares in the company, valued at $3,283,804.50. The trade was a 4.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 10.70% of the stock is owned by corporate insiders.
About TruBridge
(
Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Further Reading
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
